Alpha-Synuclein Is a Cellular Ferrireductase
2011

Alpha-Synuclein as a Cellular Ferrireductase

publication Evidence: high

Author Information

Author(s): Paul Davies, Dima Moualla, David R. Brown

Primary Institution: University of Bath

Hypothesis

Is alpha-synuclein a cellular ferrireductase responsible for reducing iron (III) to bioavailable iron (II)?

Conclusion

Alpha-synuclein functions as a ferrireductase, increasing the levels of bioavailable iron (II) in cells.

Supporting Evidence

  • Alpha-synuclein was shown to reduce iron (III) to iron (II) in the presence of copper and NADH.
  • Overexpression of alpha-synuclein in cells significantly increased the levels of iron (II).
  • Disease-associated mutations in alpha-synuclein affected its ferrireductase activity.

Takeaway

Alpha-synuclein helps turn a type of iron that cells can't use into a type they can use, which is important for brain health.

Methodology

The study used recombinant protein assays and cellular lysates to assess ferrireductase activity and metal binding.

Limitations

The study does not explore the long-term effects of altered ferrireductase activity on neuronal health.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0015814

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication